Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A2B adenosine receptor antagonists
Authors:
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (5) , 1697-1700
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A2B adenosine receptors in immunity and inflammationTrends in Immunology, 2009
- Adenosine receptors in regulation of dendritic cell differentiation and functionBlood, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Effect of A2B Adenosine Receptor Gene Ablation on Adenosine-Dependent Regulation of Proinflammatory CytokinesThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Discovery and Characterization of 4‘-(2-Furyl)-N-pyridin-3-yl-4,5‘-bipyrimidin-2‘-amine (LAS38096), a Potent, Selective, and Efficacious A2BAdenosine Receptor AntagonistJournal of Medicinal Chemistry, 2007
- New insights into the regulation of inflammation by adenosineJournal of Clinical Investigation, 2006
- Adenosine in Tissue Protection and Tissue RegenerationMolecular Pharmacology, 2005
- Hypoxia Modulates Adenosine Receptors in Human Endothelial and Smooth Muscle Cells Toward an A 2B Angiogenic PhenotypeHypertension, 2004
- Adenosine‐induced IL‐6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPKBritish Journal of Pharmacology, 2003
- Mast Cell–Mediated Stimulation of AngiogenesisCirculation Research, 2003